TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/22 20:52 | 8/9/22 | EPZM | Epizyme, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kutok Jeffery | MA | O | Chief Sc | M.d | 528 | 1.39 | 0 | 380 | 120 | D | |||||||||||||||
4/13/22 17:49 | 4/11/22 | EPZM | Epizyme, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kutok Jeffery | MA | O | Chief Sc | S | -2 | 0.9000 | 0 | -3 | -3 | 95 | D | ||||||||||||||
2/4/22 16:15 | 2/2/22 | EPZM | Epizyme, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kutok Jeffery | MA | O | Chief Sc | S | -4 | 1.37 | 0 | -3 | -3 | 97 | D | ||||||||||||||
4/7/21 06:15 | 4/5/21 | EPZM | Epizyme, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kutok Jeffery | MA | O | Chief Sc | S | -18 | 8.80 | 0 | -2 | -4 | 54 | D | ||||||||||||||
8/17/18 16:05 | 8/15/18 | INFI | Infinity Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kutok Jeffery | MA | O | Chief Sc | S.m | -29 | 2.00 | 0 | -14 | -60 | 10 | D | ||||||||||||||
6/25/18 17:00 | 6/22/18 | INFI | Infinity Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Kutok Jeffery | MA | O | Chief Sc | S | -29 | 2.00 | 0 | -14 | -39 | 22 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |